News
After questions and criticism online, Janelle Rohner says she should have disclosed her decision to take a GLP-1.
After four years, those who took GLP-1 drugs had a 7% lower risk of developing an obesity-related cancer and an 8% lower risk ...
Newly recognized issues, including extreme fatigue with excessive weight reduction, bone loss, and abdominal pain, point to ...
The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for ...
Dr. Rubinstein has years of experience working with patients to help them achieve their desired goals in a realistic, ...
Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback